Miguel Klunder-Klunder

Dr. Miguel Klunder-Klunder

Hospital Infantil de México Federico Gómez, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2014 in Diabetologia
Verified
Journal Article
Closed access
PDF file
MMMaría A. Mejía-Benítez
María A. Mejía-Benítez
ABAmélie Bonnefond
Amélie Bonnefond
LYLoïc Yengo
Loïc Yengo
MHMarlène Huyvaert
Marlène Huyvaert
ADAurélie Dechaume
Aurélie Dechaume
PFPhilippe Froguel
Philippe Froguel

1 February 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
AMAurora Mejía-Benítez
Aurora Mejía-Benítez
MKMiguel Klunder-Klunder
Miguel Klunder-Klunder
LYLoic Yengo
Loic Yengo
DMDavid Meyre
David Meyre
CACelia Aradillas-García
Celia Aradillas-García
ABAmélie Bonnefond
Amélie Bonnefond
Background: Recent genome wide association studies (GWAS) and previous positional linkage studies have identified more than 50 single nucleotide polymorphisms (SNPs) associated with obesity, mostly in Europeans. We aimed to assess the contribution of some of these SNPs to obesity risk and to the variation of related metabolic traits, in Mexican children. Methods: The association of six European obesity-related SNPs in or near FTO, NPC1, ENPP1, NEGR1, GNPDA2 and MC4R genes with risk of obesity was tested in 1,463 school-aged Mexican children (N cases = 514; N controls = 949). We also assessed effects of these SNPs on the variation of body mass index (BMI), fasting serum insulin levels, fasting plasma glucose levels, total cholesterol and triglyceride levels, in a subset of 1,171 nonobese Mexican children. Results: We found a significant effect of GNPDA2 rs10938397 on risk of obesity (odds ratio [OR] = 1.30; P = 1.34 × 10-3). Furthermore, we found nominal associations between obesity risk or BMI variation and the following SNPs: ENPP1 rs7754561, MC4R rs17782313 and NEGR1 rs2815752. Importantly, the at-risk alleles of both MC4R rs17782313 and NPC1 rs1805081 showed significant effect on increased fasting glucose levels (β = 0.36 mmol/L; P = 1.47 × 10-3) and decreased fasting serum insulin levels (β = −0.10 μU/mL; P = 1.21 × 10-3), respectively. Conclusion: Our present results suggest that some obesity-associated SNPs previously reported in Europeans also associate with risk of obesity, or metabolic quantitative traits, in Mexican children. Importantly, we found new associations between MC4R and fasting glucose levels, and between NPC1 and fasting insulin levels.

7 June 2010 in BMC Public Health
Verified
Journal Article
Open access
PDF file
CLCARLOS EMILIO JUAREZ LOPEZ
CARLOS EMILIO JUAREZ LOPEZ
MKMiguel Klunder-Klunder
Miguel Klunder-Klunder
Patricia Medina-BravoPatricia Medina-Bravo
Patricia Medina-Bravo
AMAdrián Madrigal-Azcárate
Adrián Madrigal-Azcárate
EMEliezer Mass-Díaz
Eliezer Mass-Díaz
SFSamuel Flores-Huerta
Samuel Flores-Huerta
Background: Insulin resistance is the primary metabolic disorder associated with obesity; yet little is known about its role as a determinant of the metabolic syndrome in obese children. The aim of this study is to assess the association between the degree of insulin resistance and the different components of the metabolic syndrome among obese children and adolescents. Methods: An analytical, cross-sectional and population-based study was performed in forty-four public primary schools in Campeche City, Mexico. A total of 466 obese children and adolescents between 11-13 years of age were recruited. Fasting glucose and insulin concentrations, high density lipoprotein cholesterol, triglycerides, waist circumference, systolic and diastolic blood pressures were measured; insulin resistance and metabolic syndrome were also evaluated. Results: Out of the total population studied, 69% presented low values of high density lipoprotein cholesterol, 49% suffered from abdominal obesity, 29% had hypertriglyceridemia, 8% presented high systolic and 13% high diastolic blood pressure, 4% showed impaired fasting glucose, 51% presented insulin resistance and 20% metabolic syndrome. In spite of being obese, 13% of the investigated population did not present any metabolic disorder. For each one of the components of the metabolic syndrome, when insulin resistance increased so did odds ratios as cardiometabolic risk factors. Conclusions: Regardless of age and gender an increased degree of insulin resistance is associated with a higher prevalence of disorders in each of the components of the metabolic syndrome and with a heightened risk of suffering metabolic syndrome among obese children and adolescents.

1 April 2009 in Archives of Medical Research
Verified
Journal Article
Closed access
SFSamuel Flores-Huerta
Samuel Flores-Huerta
MKMiguel Klunder-Klunder
Miguel Klunder-Klunder
LCLorenzo Reyes de la Cruz
Lorenzo Reyes de la Cruz
JSJosé Ignacio Santos
José Ignacio Santos

25 February 2013 in Pediatric Diabetes
Verified
Journal Article
Closed access
PDF file
CJCarlos Juárez-López
Carlos Juárez-López
MKMiguel Klunder-Klunder
Miguel Klunder-Klunder
AMAdrián Madrigal-Azcárate
Adrián Madrigal-Azcárate
SFSamuel Flores-Huerta
Samuel Flores-Huerta
Background Approximately 50% of obese children are insulin resistant. It has been suggested that pharmacological and nutritional options should be considered to improve the management of insulin resistance (IR). Objective To assess the effect of metformin (Met) or omega‐3 (ω‐3) polyunsaturated fatty acids (PUFA) on the homeostasis model assessment‐estimated insulin resistance (HOMA‐IR) index, lipid profile, and body mass index (BMI) of obese children. Methods We included 201 obese and insulin‐resistant children and adolescents. Ninety‐eight of them received 500 mg of Met, and 103 received 1.8 g of ω‐3 PUFA for 12 wk. This was an open‐label study with assignment of treatment based on which school the child attended. At the baseline and at the end of study, the following parameters were measured: weight, height, waist circumference, blood pressure, insulin, glucose, lipid profile, and HOMA‐IR index. There were no lifestyle interventions. Results At baseline, the age, BMI, and IR in children of both groups were comparable. The treatment assigned for each group was well tolerated. Metabolic changes were adjusted for age, sex, and change in BMI. Concerning the IR profile at the end of intervention, ω‐3 significantly decreased the concentrations of glucose and insulin while reducing HOMA‐IR values; meanwhile, Met negligibly affected insulin levels. Regarding lipids, Met increased high density lipoprotein cholesterol (HDL‐C) and decreased low density lipoprotein cholesterol (LDL‐C), but triglycerides were not affected; in contrast, triglycerides were decreased significantly by ω‐3. The effects on BMI were marginal under Met but were significant with ω‐3. Conclusion The results of this work suggest that ω‐3 may be useful as an adjuvant therapy in obese children and adolescents with IR.

20 July 2015 in Obesity
Verified
Journal Article
Open access
PDF file
Juan Manuel GALLARDOJuan Manuel GALLARDO
Juan Manuel GALLARDO
JGJaqueline Gómez‐López
Jaqueline Gómez‐López
PMPatricia Medina‐Bravo
Patricia Medina‐Bravo
FJFrancisco Juárez‐Sánchez
Francisco Juárez‐Sánchez
ACAlejandra Contreras-Ramos
Alejandra Contreras-Ramos
MKMiguel Klunder-Klunder
Miguel Klunder-Klunder
Objective: Obesity before pregnancy is associated with a greater risk for the offspring to develop obesity and diabetes in childhood and adulthood. The aim of the present study was to determine the association between maternal overweight or obesity before pregnancy and newborn oxidative stress (OS).Methods: Seventy‐two mother‐child pairs were divided according to the pre‐gestational body mass index (BMI) of the mothers as follows: eutrophic (n = 21), overweight (n = 32), and obese (n = 19). Malondialdehyde (MDA) and nitric oxide (NO) were measured in the plasma of a blood sample from the newborn's umbilical cord.Results: The MDA levels of newborns increased with maternal BMI (P = 0.001), as did the levels of NO (P = 0.019). There was a direct correlation between MDA and NO levels in each of the three groups (eutrophic: R2 = 0.59, P < 0.001; overweight: R2 = 0.45, P < 0.001; and obese: R2 = 0.26, P = 0.024).Conclusions: Maternal overweight and obesity before pregnancy are associated with increased OS in the offspring.